Category Archives

Crowdfunding psychedelics: LSD brain-imaging study seeks funds

SOURCE: Reuters

by Katie Kelland

(Reuters) – British scientists are turning to crowdfunding to complete the first scientific study ever to image the brain of someone “tripping” on the psychedelic drug LSD.

The study, part of a psychedelic research project the scientists say could revolutionize understanding of the human brain, is led by neuroscientists at Imperial College London who now need around 25,000 pounds ($38,000) to finish their work.

When they do, the research will produce the world’s first images of the human brain on LSD and will begin to reveal the way the drug can work to heal many debilitating illnesses such as alcohol addiction, depression and anxiety, the scientists told a briefing in London.

“Despite the incredible potential of this drug to further out understanding of the brain, political stigma has silenced research,” said David Nutt, a psychiatrist and professor of psychopharmacology at Imperial College London.

He accused funders and governments of “playing politics with promising science that has so much potential for good”.

LSD is one of the most potent known psychoactive drugs and was used in the 1950s and 1960s as an aid to psychotherapy for various psychiatric illnesses. It appears to break down psychological defenses and help patients open up during therapy.

But it was later banned, and under the 1971 United Nations Convention on Psychotropic Substances is now illegal almost everywhere, including in the United States, Australia, New Zealand and most of Europe. This status make it extremely difficult for scientists to research its effects in humans.

People who use psychedelic drugs often describe experiencing “expanded consciousness”, vivid imagination and dream-like states.

Nutt and other researchers have previously conducted studies with psilocybin, the psychedelic ingredient in magic mushrooms, and found it suppresses activity in certain “hub” areas of the brain that normally play a constraining role.

This latest study involves giving 20 volunteers a small dose of LSD and using the latest imaging technology to capture its effect on the brain. Nutt’s team said they expected to find that LSD’s effects were similar to those of psilocybin, but more profound and longer-lasting.

The LSD study has been funded so far with 100,000 pounds from the Beckley Foundation, a UK-based think tank dedicated to researching potential medical benefits of psychoactive substances.

The crowdfunding campaign is hosted by the science funding platform and will run for 45 days from March 5.

(Editing by Tom Heneghan)



See the campaign page on WALACEA

These Road Cyclists Want You To Sponsor Them As They crowdfund A Medical Cannabis Trial

These Cancer busting cyclists are taking on three countries, and 420km in just three days…

By James Renard

Drugs and road cycling. They’re two worlds that aren’t unfamiliar with each other. However, thanks to many a disgraced former Tour de France competitor, the drugs most of us associate with cycling are EPO, and a cocktail of steroids potent enough to put Ivan Drago on his arse.

However, you might not think cannabis and road cycling go hand in hand. Until now.

A group of enthusiastic roadies will complete a gruelling 420 kilometre bike ride to raise money for medical marijuana.

Fear not, this isn’t the plot of a Seth Rogen film. The folk taking to the road are doing so to raise money for a medical study looking at whether cannaboids – the fun bit in pot – can actually fight cancer as opposed to just elevate the symptoms as is now widely accepted in the medical community.

The ongoing study is being conducted by Dr Guillermo Velasco at the Complutense University of Madrid, and who requires the funding to continue his important work.

The Medical Cannabis Bike Tour starts in Valkenburg in the Southern tip of the Netherlands, works it way through Germany and Belgium, to the finish line in Amsterdam, all of which will take three long days.

The people taking part in the Medical Cannabis Bike Tour are looking for sponsorship from both private individuals and businesses, so if you think you can help, see their website for details on how to donate, along with further information on the study in Madrid.

Human Trial Investigating Cannabis As A Brain Cancer Treatment Set To Begin This Year

By Justin Alford, 13th June 2015.

Follow Justing in Twitter: @lamanaeblue

Glaucoma, pain, nausea, loss of appetite, epilepsy and multiple sclerosis; the list of ailments that medical marijuana shows promise in treating seems to be steadily growing. But what about the disease most people seem to be interested in, cancer? Despite an abundance of anecdotal evidence supporting its use, clinical trials are virtually non-existent.

But cell culture and animal studies for one type of brain cancer, glioma, have been so promising that scientists are now crowdfunding for a new human study to investigate its potential therapeutic benefits. And given the overwhelmingly positive public response that this same start-up crowdfunding platform, Walacea, received earlier this year when reaching out for funds for a human LSD brain imaging project, it seems likely that the campaign will be a success.

“Donating to cannabis medical research is essential to highlight the potential of cannabinoids to treat a range of conditions,” Jorge Cervantes, horticulturalist and medical cannabis advocate, said in a statement.

But if these cannabinoids –the biologically active compounds found in cannabis plants– hold so much promise, why is public money needed to fund such important research? Like heroin and LSD, marijuana remains a Schedule 1 drug, meaning it is either deemed as having no accepted medical treatment use or there is a lack of accepted safety for its use. That’s despite the fact that it has been legalized for medicinal or personal use in some US states. Unfortunately, the resulting controls placed on drugs within this category makes scientific research into their therapeutic uses virtually impossible.

“The law is there to protect people,” Natalie Jonk, founder of Walacea, tells IFLScience. “Yet by making cannabis a schedule 1 drug, it makes people who wish to benefit from its medicinal properties criminals.” Cancer patients wishing to use the drug therapeutically are also forced to rely on forums and personal experience, which is dangerous as doses are not based on clinical evidence.

Gliomas are a common type of brain cancer, accounting for around 45% of cases. Because they have a tendency to grow into normal brain tissue, surgical removal is exceedingly difficult and often bits of tumor remain despite a surgeon’s best efforts, offering the opportunity for the cancer to return or spread to other body sites. This, combined with the fact that this organ is inaccessible to many therapeutic agents, thanks to its protective blood-brain barrier (BBB), means that gliomas are notoriously tricky to treat.

Here’s where cannabis comes in: cannabinoids can rapidly cross the BBBexerting various effects by mimicking natural substances produced by our body, the endocannabinoids, which stick to and activate so-called cannabinoid receptors. One such effect is their apparent antitumor activity, demonstrated in various different cancerous tissues in the lab.

Encouragingly, cannabinoids seem to cause cells that drive glioma progression and recurrence, called glioma-initiating cells, to self-destruct in the lab, a process known as apoptosis. If the substances can do the same things in glioma patients, then scientists are hopeful they may represent a novel way to tackle these cancers. But until scientists conduct proper controlled trials, we won’t know whether this is the case or not.

Hopefully, if this proposed trial goes ahead, we may finally glean some long-anticipated answers. The program is due to commence this Autumn, conducted across 4-6 Spanish hospitals. It will involve between 30-40 glioma patients who will be administered cannabinoids in combination with other anticancer drugs.

Alongside the crowdfunding effort, which seeks to raise £60,000, volunteers are hoping to raise an additional £200,000 from a sponsored 420 kilometer bike ride, which ends on 14 June.

Science crowdfunding startup launches cannabis cancer cure research campaign


By Kirsty Styles

Science crowdfunding startup Walacea is helping Madrid’s MedicalCannabis Bike Tour to raise the final €85,000 it needs to conduct an independent clinical trial into the effect of cannabinoids on brain tumours.

The scientists behind the tour have been working for the past 10 years to find ways to use cannabinoids, a substance found in cannabis, to treat breast cancer, skin cancer and brain tumours.

They have been fundraising since 2012 to get the cash they need for the trial in Spanish hospitals and have so far raised  €200,000.

“Pharmaceutical companies have already started patenting new drugs based on cannabinoids, through crowdfunding this research we hope to make new therapies available at a fraction of the cost by funding the research without patenting effective treatments,” said founder of Walacea Natalie Jonk.

Walacea participated in the summer 2014 programme of Bethnal Green Ventures, which aims to help socially good startups get off the ground.

The platform is named after the lesser known “co-founder of evolution” Alfred Russel Wallace, explains Jonk, who “effectively crowdfunded his research during the late 1800s”.

Walacea, which offers small rewards for people pledging to back scientific breakthroughs, made headlines back in February after crowdfunding the world’s first MRI images of the brain on LSD.

Crowdfunded LSD Study Raises Double The Goal

By Robin Burks,

Tech Times | April 20, 4:00 PM

When British scientists turned to crowdfunding to raise money for research into LSD’s effects on the brain, they had no idea they would get double the amount they asked for.

But that’s exactly what happened, and the world’s first real “Brain On LSD” study is now underway.

After raising over £53,000 or almost $80,000 on crowdfunding site Walacea – double the original goal of £25,000 – the team of scientists will scan brains under the effects of LSD for the first time ever. This sort of research hasn’t been done before because of the drug’s illegality, as well as the stigma that comes with its use.

LSD is one of the strongest psychoactive drugs ever created. The drug found use in the 1950s and 1960s for psychotherapy, but following the 1971 United Nations Convention on Psychotropic Substances, LSD was banned almost everywhere in the world. Regardless of its potential for treating mental illnesses, LSD’s illegality has prevented sufficient research into its effects on the brain.

“Despite the incredible potential of this drug to further our understanding of the brain, political stigma has silenced research,”said psychiatrist David Nutt, from Imperial College London.

The study has already begun, and the funds of the crowdfunding campaign will help complete the research. The study, co-authored by Nutt, Robin Carhart-Harris and Amanda Feilding gives volunteers LSD and then scans their brains with fMRI and MEG machines. This should show researchers where LSD affects the brain, as well as indicating how the drug could potentially be used to help those with mental illnesses.

“Understanding more about the physiological effects of LSD will help us shed light on potential medical interventions as well as help us learn more about consciousness,” reads the description on the crowdfunding page. “In many respects how the brain works is still a mystery. By researching how psychedelics work, we will be a step closer to understanding how specific areas of the brain are affected to induce certain psychological effects.”

The same research team conducted a recent study on psilocybin, the main ingredient in “magic mushrooms.” Their work showed that psilocybin affects parts of the brain also affected by depression, OCD, Alzheimer’s and autism. They expect that their findings with LSD will have similar results.

In 2014, another team of researchers conducted a small study on LSD and found the drug effective in decreasing anxiety.

Nutt and his colleagues hope to release the findings of their study later this year.

46 countries are backing the world’s first LSD brain imaging study

crowdfunding campaign for the world’s first ever images of the brain on LSD has smashed its initial financial goal of £25,000 in just 36 hours.

Over 1,200 people in 46 countries jumped in support of the study, as part of the collaboration between the Beckley Foundation and Imperial College London, and has since raised nearly £45,000.

The study aims to uncover the physiological effects psychedelics actually have on the brain as well as revealing ways they could work to heal many debilitating conditions such as obsessive compulsive disorder, alcohol dependence, anorexia, obesity and depression.

“Investigating the potential benefits of currently ‘controlled’ substances should not be an obstacle course, it should be encouraged,” said Amanda Feilding, the director of the Beckley Foundation Psychedelic Research Programme.

“This should be particularly the case for psychedelics, whose low risk profile and promising therapeutic potential do not warrant the draconian censorship imposed on them.”

Scientists use crowdfunding to boost research into LSD effects on the brain

SOURCE: The Pharmaceutical Journal

By Ingrid Torjesen

A team of researchers at Imperial College London require £25,000 to continue their study to analyse the effects of LSD on the brain.

Scientists have turned to crowdfunding to support an imaging study showing the effects of LSD on the brain, the first to be conducted in the UK.

The team has begun a psychedelic research programme with £100,000 of funding from The Beckley Foundation. However, the group needs a further £25,000, which they are attempting to raise through the crowdfunding website Walacea. The crowdfunding campaign will run for 45 days from 5 March 2015.

Despite the incredible potential of this drug to further our understanding of the brain, political stigma has silenced research,” says David Nutt, the principal investigator and a professor of neuropsychopharmacology at Imperial College London. “We must not play politics with promising science that has so much potential for good.”

The researchers administered a 75μg IV dose of LSD to 20 subjects and used both functional MRI and magnetoencephalography (MEG) imaging to record the effects. fMRI records snapshots of activity taking place in the brain and MEG measures oscillating neuroactivity. The rest of the funding is needed to fully analyse the results.

Numerous studies were conducted on LSD in the 1950s and 1960s, but then the drug was made illegal. In the past 50 years, there have only been three studies undertaken due to the difficulty and costs of obtaining the necessary licences to conduct the research, and the struggle of finding funders willing to support it. None of these studies have been conducted in the UK.


Nutt was previously chair of the UK government’s Advisory Committee on the Misuse of Drugs, but was sacked in 2009 after advising the government not to toughen laws on cannabis by reclassifying it from C to B and recommending that ecstasy be downgraded from class A.

The research at Imperial College has previously focused on the effects of psilocybin, the active compound in magic mushrooms, on the human brain. The group previously carried out a similar imaging study of the brains of subjects who had taken IV psilocybin. Psilocybin was found to decrease the blood supply to the brain, particularly in what is known as the default mode network (DMN), a network in the brain responsible for coordinating and censoring the different areas in the brain involved in conscious awareness, and caused a “de-synchrony in the activity” of the brain. They predict similar but more powerful effects from LSD.

Crowdfunding Video darüber, was LSD im Hirn auslöst

Spannende Kiste: Eine Untersuchung dessen, was LSD während seiner Wirkung im Kopf tatsächlich auslöst. Gab es so noch nicht. Jetzt versucht man die Kosten für eine derartige Studie per Crowdfunding zusammen zu bekommen, was bereits schon jetzt geschafft ist. Ich freue mich auf das Ergebnis dessen, was dabei herauskommen wird. Kümmert sich ja sonst keiner drum.

    • Terms of Agreement
      • The following Terms and Conditions constitute a legally binding agreement between Crowd.Science and Crowd.Science’s members.
      • This agreement outlines the terms and conditions that govern member use as a Campaign Owner, Campaign Funder or third party and includes anyone acting on the Campaign Owner or Campaign Funder’s behalf or with the Campaign Owner or Campaign Funder’s express or implied authority of our services at www.Crowd.Science (”Crowd.Science”).
      • It is the member’s responsibility to read and comply with these Terms and Conditions and CrowdScience’s Privacy Policy before the member registers, launches a campaign or funds a campaign.
      • The member’s use of Crowd.Science is contingent upon Crowd.Science’s Privacy Policy and these Terms and Conditions.
      • Use of Crowd.Science will be considered acceptance of Crowd.Science’s Terms and Conditions and Privacy Policy.
      • Science reserves the right to modify these Terms and Conditions and/or Privacy Policy from time to time without notice.
      • Science’s Privacy Policy may be accessed on our website
      • Amended Terms and Conditions and/or Privacy Policy will be effective immediately and the member’s continued use of Crowd.Science will constitute acceptance of such changes.
      • The member also undertake to familiarise themself with Campaign Owners and Campaign Funders must also agree and comply with the Stripe Acceptable Use Policy and the terms and conditions on other websites operated by Crowd.Science and its related and affiliated companies, to the extent that the member uses those websites. Stripe is the payment gateway which Crowd.Science uses.
      • Nothing in this Agreement creates a partnership, employment relationship or agency between the member and Crowd.Science.
      • This Agreement may not be assigned in whole or in part, to any third party without Crowd.Science’s prior written consent, and any attempt to do so will be invalid.
      • Should any part of this Agreement be held invalid or unenforceable, that portion will be construed consistent with applicable law and the remaining portions will remain in full force and effect.
      • Failure by Crowd.Science to enforce any provision of this Agreement will not be considered a waiver of the right to enforce such provision and Crowd.Science’s rights under this Agreement will survive any termination of this Agreement.
    • Member usage
      • Members warrant that Campaigns listed and information provided to Crowd.Science or other members in the registration or listing process, in any public message area (including the discussion boards and in feedback) or through any email feature are true and correct.
      • Members are solely responsible for the information that they provide on Crowd.Science.
      • Members warrant that they are 18 years of age and have capacity to enter into a legally binding contract and accept these terms and conditions.
    • Definitions
      • “Campaign” means scientific research proposal, issues or causes as registered on Crowd.Science by the Campaign Owner.
      • Campaign Deadline” means the period in which Crowd.Science decides that the Campaign Owners fundraising period expires;
      • “Campaign Owners” means individuals, groups and organisations (as approved by Crowd.Science moderators) who have registered a Campaign on Crowd.Science.
      • “Campaign Funders” means individuals, groups and organisations that fund Campaign Owners campaigns in exchange for Rewards.
      • “Campaign Reward” means items, experiences or services offered by Campaign Owners to Campaign Funders in exchange for Campaign Funders funding Campaigns.
      • “Crowd.Science” means the Crowd.Science website platform and software and includes Crowd.Science’s agents, employees, subcontractors and suppliers.
      • “Crowd.Science moderators” means a moderator approved by Crowd.Science to decide which Campaigns are eligible to raise funds on Crowd.Science.
      • “Crowd.Science’s service” means the service provided by Crowd.Science to provide an online platform for Campaign Owners to raised funds for their Campaign;
      • “Copyright” means Copyright as per the Copyright Act 1968 (Cth);
      • “Funds” means the funds raised by the Campaign Owner as provided by the Campaign Funder
      • “Force Majeure” means the occurrence of any event or circumstance beyond the reasonable control of Crowd.Science.
      • “VAT” refers to tax
      • “the member” means the Campaign Owner, Campaign Funder or third party and includes anyone acting on the behalf of a Campaign Owner or Campaign Funder or with express or implied authority.
      • “Intellectual Property Rights” means patents, Trademarks, service marks, design rights (registrable or otherwise) applications for any of the foregoing, Copyright, database rights, trade or business names and other similar rights or obligations whether registrable or not in any country (including but not limited to Australia);
      • “Trust Account” means the trust account held by the Nominated body that will hold the funds raised by the Campaign Owner from the Campaign Funders.
    • Science’s Service
      • Science is an online crowdfunding service and acts as a venue to allow members who comply with Crowd.Science’s Terms and Conditions and Policies to raise funds for their scientific proposals, or to contribute funding to scientific proposals.
      • Science allows approved Campaign Owners to list Campaigns and raise funds through offering Rewards to new and existing Campaign Funders.
    • Science has limited liability
      • Science is not directly involved in the transaction between Campaign Owners and Campaign Funders. As a result, Crowd.Science will not be liable for the control, quality, safety, morality or legality of any aspect of the Rewards listed or the truth or accuracy of the listings, the ability of Campaign Owners to sell Rewards or the ability of Campaign Funders to pay for Rewards.
      • Science cannot ensure that a Campaign Funder or a Campaign Owner will actually complete a transaction and is not liable for any loss to the Campaign Funder or Campaign Owner.
      • Science does not transfer legal ownership of Rewards from the Campaign Funder to the Campaign Owner and is not liable for any failure by the Campaign Owner to provide a Reward to the Campaign Funder.
      • Science cannot guarantee the true identity, age, and nationality of any member.
      • Science is not responsible or liable for any content (data, text, information, graphics, images, photographs, profiles, audio, video, items, and links) posted by members or third parties on Crowd.Science. Crowd.Science does not take any responsibility for any loss caused to the Campaign Owner or Campaign Funder arising directly or indirectly from any failure or delay caused by the Campaign Owner or Campaign Funder or by reason of any event or circumstance outside of the reasonable control of Crowd.Science or due to Force Majeure.
      • It is the responsibility of the Campaign Owner/Campaign Funder to take precautions to ensure that whatever computer equipment and/or software used is free from viruses, worms, Trojans and other items of a destructive nature.
      • Science shall not be liable for the interactions with any organisations and/or individuals found on or through the Crowd.Science service. This includes, but is not limited to, delivery of goods and services, and any other terms, conditions, warranties or representations associated with listings on Crowd.Science.
      • .Crowd.Science cannot be held liable for the actions of a Campaign Owner; Campaign Owners are wholly responsible for fulfilling obligations both implied and stated in any campaign listing they create.
      • Science does not oversee the performance or punctuality of Campaigns.
      • Science reserves the right to cancel a campaign listing and cancel all pledged payments at any time for any reason.
      • Science reserves the right to remove a campaign listing from public listings for any reason.
      • Science is not responsible for any damage or loss incurred as a result of any dealings on the Crowd.Science platform.
      • Science is under no obligation to become involved in disputes between Campaign Funders and Campaign Owners, or between site members and any third party. In the event of a dispute, you release Crowd.Science employees, partners and successors in rights from claims, damages and demands of every kind, known or unknown, suspected or unsuspected, disclosed or undisclosed, arising out of or in any way related to such disputes and our service.
      • Science cannot guarantee the performance or reliability of the STRIPE online payment service. Additionally, because of occasional failures of some credit cards, Crowd.Science cannot guarantee the full receipt of the total funds pledged to a Campaign Owner’s campaign.
      • Science cannot guarantee the full receipt of pledged funds Campaign Funders due to occasional failures when capturing funds from debit and credit cards.
      • While Crowd.Science may provide basic moderation to listed Campaigns, Crowd.Science is under no obligation to do so, and Campaign Funders are responsible for due diligence before pledging any funding to Campaign Owners.
      • This limitation of liability section shall prevail over any conflicting or inconsistent provision contained in these Terms and Conditions.
    • How Campaigns Work
      • Campaign Owners register as members on Crowd.Science.
      • Campaign Owners register their Campaign on Crowd.Science for approval by Crowd.Science.
      • Science moderators assess the Campaign.
      • If Crowd.Science moderators accept the Campaign Owners Campaign, Crowd.Science will register the Campaign and open the Campaign to receive funds from Crowd.Science in exchange for Rewards as provided to Campaign Funders by the Campaign Owners (if applicable).
      • All funds are collected for Campaign Owners from Campaign Funders through the Stripe online payment service.
      • Campaign Funds are then transferred into the Campaign Owner for the Campaign Owner to then transfer into their Nominated Account in line with their university policy.
      • Science collects and transfers these pledged funds to the Campaign Owner at the Campaign Deadline if the campaign goal has been reached.
    • Campaign Owner and Campaign Funder Obligation
      • By launching a Campaign on Crowd.Science, the Campaign Owner agrees that all funds raised will be used for conducting the research proposed in their campaign.
      • If more funds are raised than the goal specified, the Campaign Owner must use the funding for conducting related research or refund the excess to the backers.
      • As a Campaign Owner, Campaign Funder or member you accept and agree that Crowd.Science is not responsible for the transfer of funds after Crowd.Science has transferred funds to the Campaign Owner.
      • Science is under no obligation to become involved in disputes between backers and researchers or between site members and any third party
      • Science does not oversee the performance or punctuality of projects.
      • Science cannot be held liable for the actions of a researcher, researchers are wholly responsible for fulfilling obligations both implied and stated in any project listing they create.
      • [Funders] It is solely your choice to contribute to a project and contributing to a project does not give you any rights in or to that project
      • [Funders] Any perks offered to you are between you and the researcher only and Crowd.Science does not guarantee that they will be of satisfaction to you.
    • Campaign Rewards
      • By listing a Reward on Crowd.Science the Campaign Owner warrants that all aspects of the Reward comply with Crowd.Science’s published policies.
      • The Campaign Owner warrants that the Reward may be legally sold.
      • The Campaign Owner must accurately describe the Rewards and all terms of sale in the Campaign Description and the Reward Description.
      • Reward Descriptions may only include text descriptions, graphics, pictures, videos, photographs and other content relevant to the sale of that Reward.
      • Rewards must accurately and completely describe the item(s) or experiences on offer. If the available quantity of the Reward is more than one or unlimited, all items and/or experiences listed in that Reward tier must be identical.
      • Each unique Reward must have its own listing as a new Reward.
      • All Campaign Owners are urged to outline seller policies for their Campaigns. These policies may include, for example, shipping, returns, payment and selling policies.
      • Campaign Owners must create reasonable policies in good faith and must abide by such policies. All seller policies must comply with Crowd.Science’s site-wide policies.
      • Campaign Owners are responsible for enforcing their own reasonable seller policies.
      • Science reserves the right to request that a Campaign Owner modify a seller policy.
      • All Reward sales are binding on the Campaign Owner.
      • The Campaign Owner is wholly responsible for meeting any obligation or Reward stated or implied in their campaign. Crowd.Science is not responsible for the delivery of Rewards stated in campaigns. Campaign Funders should contact the Campaign Owner if the delivery terms are not clearly stated in the project description.
      • The Campaign Owner is obligated to provide the Reward(s) or otherwise complete the transaction with the Campaign Funder.
    • Fees Payable to Crowd.Science
      • Registering as a member and setting up a Campaign on Crowd.Science is free.
      • Science charges fees to Campaign Owners at the conclusion of the campaign or whenever the Campaign Owner chooses to collect the pledged funds. Funds can only be collected once the campaign has reached its goal.
      • Science will initiate a capture of all funds from Campaign Funders and transfer the funds to the Campaign Owner (minus the Crowd.Science fees).
      • Science charges a service fee of 5%, which is deducted from the total amount of funds raised at the end of the campaign.
      • Science charges a transaction fee for Credit / Debit Card on Crowd.Science 2% + 30p per transaction (UK) to cover costs incurred from the stripe payment gateway.
      • There is a 7 – 10 business day processing period (after the end of a Campaign) in which supporters who have had their pledges declined are invited to resubmit their pledge.
      • Science may change fee policies and the fees for services.
      • Science may choose to temporarily change our fees policy and the fees for our services for promotional events (for example, free service days) and such changes are effective when we post the temporary promotional event.
      • If Crowd.Science introduces a new service, the fees for that service are effective at the launch of the service.
      • Unless otherwise stated, all fees are quoted in the currency of the project.
      • The member is responsible for paying all fees associated with using our services and all applicable taxes (including any goods and services or value added taxes, which will be added to amounts billed to you, if applicable).
      • The member should consider Crowd.Science fees when determining the funding goal of Campaigns.
      • The campaign owner is responsible for paying any taxes that may be required e.g. if the funding is paying for salaries.
    • Stripe Payment Gateway
      • Campaigners and contributors must agree to comply with Stripe Terms and Conditions.
    • Refunds
      • Science transfers the funds to the Campaign Owner after the campaign deadline.
      • Funds collected through the Crowd.Science platform are non-refundable and Crowd.Science is not responsible for issuing refunds to Campaign Funders
      • Campaign Funders may initiate refunds at their own discretion.
      • If, for any reason, Crowd.Science is required to refund monies to Campaign Owners, the Campaign Owner will fully compensate Crowd.Science for the amount refunded as well as any associated costs, including but not limited to transaction or administrative costs.
      • The member agrees that any attempt to obtain a refund without first having obtained prior written consent to refund shall entitle Crowd.Science to deactivate the member’s account unless and/or until such time as the fees are repaid or a credit or refund is agreed with Crowd.Science.
    • Communications with Crowd.Science
      • Communications between the Member and Crowd.Science are to be in electronic form.
      • The member consents to receive communications and notice from Crowd.Science electronically and agrees that all terms and conditions, agreements, notices, disclosures, and other communications that Crowd.Science satisfy any legal requirement that such communications would satisfy if it were in writing.
    • Tax and legal compliance
      • In addition to these terms and conditions the member must familiarise them self with, and comply with the Policies, domestic laws (including common law), country legislation, international laws, statutes, ordinances and regulations regarding use of Crowd.Science  services including listing and supporting Campaigns.
      • Campaign Owners should be aware that funds raised using Crowd.Science could be taxable income. It is the Campaign Owner’s responsibility to declare the funds and comply with local tax laws.
      • Campaign Owners alone, and not Crowd.Science, are responsible for ensuring that the campaign listing and any other activities conducted on the Crowd.Science website are lawful.
      • Campaign Owners must ensure that they comply with all applicable laws in UK and all other countries.
      • Campaign Owners must also ensure that they strictly comply with these term and conditions and the policies, which form part of the agreement.
    • Dispute Resolution
      • The member shall attempt to resolve all disputes arising out of these Terms and Conditions in a spirit of cooperation without formal legal proceedings.
      • Any dispute which cannot be resolved and other than injunctive relief shall be subject to mediation upon written demand of the member to Crowd.Science and any notice of dispute shall be provided within seven (7) days of the dispute arising.
    • Governing Law and Jurisdiction
      • These terms and conditions are governed in all respects by the laws of the United Kingdom and any action arising under them or in any way connected with the Crowd.Science service may be brought only in a court in the United Kingdom, subject to any law, which is expressly inconsistent with this.
      • The members irrevocably agree that the courts of United Kingdom are to have exclusive jurisdiction to settle any disputes which may arise.
    • Third Party Site
      • The site may permit [campaigners] to link to other website or resources on the internet and other third party websites. Crowd.Science is not responsible for the content, functions, accuracy, privacy policy, legality, appropriateness or any other aspect of any external links or sited resources.
      • Science is not responsible or liable directly or indirectly for any claims, demands, damages against Crowd.Science arising from or in connection with any damage or loss caused or alleged by on in connection with your use of or reliance on any such contect, goods or services available through any external links or resources
    • Prohibited Use Of Crowd.Science
      • Science staff and appointed members may moderate campaigns and other content (data, text, information, graphics,   images, photographs, profiles, audio, video, items, and links) on the Crowd.Science platform.

    The member is solely responsible for the member’s conduct and activities on the Crowd.Science venue and any and all data, text, information, graphics, images, photographs, profiles, audio, video, items, and links (together, “Content”) that are submitted, posted, and displayed on the Crowd.Science venue.The member’s content and use of Crowd.Science shall not: be false, inaccurate or misleading; be fraudulent or involve the sale of illegal, counterfeit or stolen items; infringe upon any third-party’s copyright, patent, trademark, trade secret or other proprietary or intellectual property rights or rights of publicity or privacy; violate this Agreement, any site policies, any site guidelines, or any applicable laws, statute, ordinance or regulation (including, but not limited to, those governing export control, consumer protection, unfair competition, anti-discrimination or false advertising); contain items that have been identified by your local government as hazardous to consumers and therefore subject to a recall; be defamatory, libellous, unlawfully threatening, unlawfully harassing, or impersonate or intimidate any person (including Crowd.Science staff or other users), or falsely state or otherwise misrepresent affiliation with any person, through for example, the use of similar email address, nicknames, or creation of false account(s) or any other method or device; be obscene or contain pornography, child pornography or explicit content; contain or transmit any code of a destructive nature that may damage, detrimentally interfere with, surreptitiously intercept or expropriate any system, data or personal information; modify, adapt or hack Crowd.Science or modify another website so as to falsely imply that it is associated with Crowd.Science; appear to create liability for Crowd.Science or cause Crowd.Science to lose (in whole or in part) the services of Crowd.Science’s ISPs or other suppliers; link directly or indirectly, refer or contain descriptions of goods, experiences or services that are prohibited under this Agreement, the Privacy Policy, or other policy documents as posted on Crowd.Science; Members must not list any Reward on Crowd.Science (or consummate any transaction that was initiated using Crowd.Science’s service) that, by paying to Crowd.Science the transaction or fee, could cause Crowd.Science to violate any applicable law, statute, ordinance or regulation, or that violates these Terms and Conditions; Crowd.Science reserves the right to terminate a member’s access to Crowd.Science if Crowd.Science suspects, after investigation, that they have misused the Crowd.Science service, violated the terms of this Agreement, or have otherwise used the Crowd.Science service to conduct any fraudulent or illegal activity or breached Crowd.Science’s Terms and Conditions; In the event an account is suspended or terminated for breach of this Agreement (in each case as determined in Crowd.Science’s sole discretion), Crowd.Science may suspend or terminate the account associated with such breach and any or all other accounts held by you or your affiliates, and your breach shall be deemed to apply to all such accounts.